Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Practical Course HP-F13: Molecular and Immunological Methods in Tumor Virology

Type: Practical Course with Student Seminars

Date: 8.-26. July 2024

Hosts/Supervisors: Martin Müller (responsible organizer contact:, Stella Autenrieth, Marco Binder, Timo Bund, Henri-Jacques Delecluse, Susanne Delecluse, Aoife Gahlawat, Tim Waterboer

Topics and Content:


Order of weeks is variable. Experiments will be carried out in groups of 2-3 students. During the course, each student is required to present a seminar with background information relevant to the experiments being performed. Both classical virological techniques as well as modern molecular and cell biological methods will be employed.


Week 1 (M. Müller & T. Waterboer/A. Gahlawat):

Preparation of virus-like particles from baculovirus infected insect cells and their analysis by ultracentrifugation and Western blot and ELISA.
Processing of cancer patient blood and biobanking. Multiplex serology for the analysis of cytokines in HPV+ cancer.

Week 2 (S. Autenrieth & M. Binder):

Innate immune responses to viral infection will be investigated. Cell-intrinsic induction of antiviral defenses will be studied in virus infected A549 epithelial cells and their supernatants. Furthermore, immune cells (PBMCs) will be stimulated by incubation with bacteria or a virus, or by co-cultivation with virus infected A549 cells. Supernatants will be analyzed for presence of cytokines by ELISA, and for their antiviral activity in a bioassay. Lastly, activation of immune cells will be analyzed by spectral flow cytometry (an advanced version of FACS).

Week 3 (H.-J & S. Delecluse; T. Bund):

The first practical (days 1+2) will use life cell imaging to characterize cells infected with the Epstein-Barr virus.
Preparation of virus-like particles from baculovirus infected insect cells and theiranalysis by ultracentrifugation and western blot and ELISA. In addition, AAV gene transfer vectors derived from different serotypes will be titrated using ELISA and PCR. The vectors will be used for gene transfer of reporter genes into cell lines.

to top
powered by webEdition CMS